Seeing Is Believing
Currently out of the existing stock ratings of Karina Rabayeva, 1 are a BUY (100%).
Analyst Karina Rabayeva, currently employed at TRUIST,
Karina Rabayeva’s has documented 2 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on JANX, Janux Therapeutics at 10-Sep-2025.
Analyst best performing recommendations are on JANX (JANUX THERAPEUTICS).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Sep-2024
$55
$38.34 (230.13%)
$58
2 months 23 days ago
(07-Aug-2026)
0/7 (0%)
$39.15 (247.00%)
Buy Since 19-Aug-2025
$26
$11.06 (74.03%)
$30
5 months 22 days ago
(08-May-2026)
0/3 (0%)
$11.82 (83.36%)
Buy Since 06-Apr-2023
$36
$21.06 (140.96%)
$74
5 months 22 days ago
(08-May-2026)
5/8 (62.5%)
$21.82 (153.88%)
232
Buy Since 22-Nov-2024
$45
$28.34 (170.11%)
$89
6 months 2 days ago
(28-Apr-2026)
0/4 (0%)
$30.5 (210.34%)
Buy Since 17-Sep-2025
$14
$-2.66 (-15.97%)
$29
6 months 10 days ago
(20-Apr-2026)
1/4 (25%)
$-1.87 (-11.78%)
25
What Year was the first public recommendation made by Karina Rabayeva?